These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25877762)

  • 1. Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy.
    Dahlén R; Magnusson MK; Bajor A; Lasson A; Ung KA; Strid H; Öhman L
    Scand J Gastroenterol; 2015; 50(9):1118-26. PubMed ID: 25877762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition.
    Magnusson MK; Strid H; Sapnara M; Lasson A; Bajor A; Ung KA; Öhman L
    J Crohns Colitis; 2016 Aug; 10(8):943-52. PubMed ID: 26896085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
    Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R
    Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C.
    Magnusson MK; Strid H; Isaksson S; Bajor A; Lasson A; Ung KA; Öhman L
    J Crohns Colitis; 2015 Jan; 9(1):56-65. PubMed ID: 25518051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile.
    Kumawat AK; Strid H; Tysk C; Bohr J; Hörnquist EH
    Mol Immunol; 2013 Oct; 55(3-4):355-64. PubMed ID: 23566938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
    Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
    Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis.
    Olsen T; Cui G; Goll R; Husebekk A; Florholmen J
    Scand J Gastroenterol; 2009; 44(6):727-35. PubMed ID: 19294580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
    Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
    World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.
    Wine E; Mack DR; Hyams J; Otley AR; Markowitz J; Crandall WV; Leleiko N; Muise AM; Griffiths AM; Turner D
    J Crohns Colitis; 2013 Dec; 7(11):916-22. PubMed ID: 23339932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of inflammatory genes in the colon of ulcerative colitis patients varies with activity both at the mRNA and protein level.
    Verma R; Verma N; Paul J
    Eur Cytokine Netw; 2013; 24(3):130-8. PubMed ID: 24197332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea.
    Biesiada G; Czepiel J; Ptak-Belowska A; Targosz A; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T; Mach T
    J Physiol Pharmacol; 2012 Oct; 63(5):471-81. PubMed ID: 23211301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.
    Olsen T; Rismo R; Gundersen MD; Paulssen EJ; Johnsen K; Kvamme JM; Goll R; Florholmen J
    Cytokine; 2016 Mar; 79():90-5. PubMed ID: 26775117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase.
    Masuda H; Iwai S; Tanaka T; Hayakawa S
    J Clin Lab Immunol; 1995; 46(3):111-23. PubMed ID: 8926619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis.
    Hozumi H; Hokari R; Kurihara C; Narimatsu K; Sato H; Sato S; Ueda T; Higashiyama M; Okada Y; Watanabe C; Komoto S; Tomita K; Kawaguchi A; Nagao S; Miura S
    Int J Colorectal Dis; 2013 Aug; 28(8):1049-55. PubMed ID: 23377880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis.
    Sato S; Chiba T; Nakamura S; Matsumoto T
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1467-72. PubMed ID: 25968585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
    Iboshi Y; Nakamura K; Fukaura K; Iwasa T; Ogino H; Sumida Y; Ihara E; Akiho H; Harada N; Nakamuta M
    J Gastroenterol; 2017 Mar; 52(3):315-326. PubMed ID: 27178567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.